Vasculitis & polymyalgia rheumatica
Gastrointestinal dysmotility complicating Behçet's syndrome: description of a newly recognised clinical phenotype
Authors' conclusion
Gastrointestinal dysmotility may arise in BS and is effectively treated by apheresis.
Study context
- Population
- Patients with Behçet's syndrome (BS) presenting with symptoms of and investigations compatible with an immune associated disorder of gastrointestinal motility, or enteric neuropathy
- Participants
- 7 patients
- Outcome
- Clinical features, investigation results and response to apheresis
Main finding
As reported in the abstract
- Response to apheresis not only of the enteric neuropathy but also of the systemic features of the disease, despite previous maximal immunosuppressive therapy in most cases
Observational data: associations, not effects.
Original publication
Gastrointestinal dysmotility complicating Behçet's syndrome: description of a newly recognised clinical phenotype. Clin Exp Rheumatol. Published 30 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →